Profil
Keith M.
Fournier is Director at NetraMark Holdings, Inc. since 2026.
Dr. Fournier is Senior Vice President-Global Regulatory Affairs at Abivax SA since 2026.
Formerly, Dr. Fournier was Vice President-Global Regulatory Affairs at EMD Serono, Inc. Education includes undergraduate studies at Duke University and a doctorate from the University of Pennsylvania Medical Center.
Aktive Positionen von Keith Fournier
| Unternehmen | Position | Beginn |
|---|---|---|
| ABIVAX | General Counsel | 19.03.2026 |
| NETRAMARK HOLDINGS INC. | Direktor/Vorstandsmitglied | 01.09.2026 |
Ehemalige bekannte Positionen von Keith Fournier
| Unternehmen | Position | Ende |
|---|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | General Counsel | - |
Ausbildung von Keith Fournier
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Abivax SA
Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
University of Pennsylvania Medical Center
University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NetraMark Holdings, Inc.
NetraMark Holdings, Inc. Packaged SoftwareTechnology Services Develops app that provides brain health solutions | Technology Services |
















